KEMRI Centre for Geographic Medicine Research - Coast, and Wellcome Trust Research Programme, Nairobi, Kenya.
Trop Med Int Health. 2011 Jan;16(1):97-104. doi: 10.1111/j.1365-3156.2010.02637.x. Epub 2010 Oct 19.
Increasingly attention is shifting towards delivering essential packages of care, often based on clinical practice guidelines, as a means to improve maternal, child and newborn survival in low-income settings. Cost effectiveness analysis (CEA), allied to the evaluation of less complex intervention, has become an increasingly important tool for priority setting. Arguably such analyses should be extended to inform decisions around the deployment of more complex interventions. In the discussion, we illustrate some of the challenges facing the extension of CEA to this area. We suggest that there are both practical and methodological challenges to overcome when conducting economic evaluation for packages of care interventions that incorporate clinical guidelines. Some might be overcome by developing specific guidance on approaches, for example clarity in identifying relevant costs. Some require consensus on methods. The greatest challenge, however, lies in how to incorporate, as measures of effectiveness, process measures of service quality. Questions on which measures to use, how multiple measures might be combined, how improvements in one area might be compared with those in another and what value is associated with improvement in health worker practices are yet to be answered.
越来越多的人开始关注提供基本的医疗护理包,这些护理包通常基于临床实践指南,作为改善低收入环境下孕产妇、儿童和新生儿生存的一种手段。成本效益分析(CEA)与对较不复杂干预措施的评估一道,已成为确定优先事项的一个日益重要的工具。可以说,这种分析也应该扩展到为更复杂干预措施的部署提供决策依据。在讨论中,我们举例说明了将 CEA 扩展到这一领域所面临的一些挑战。我们认为,在对纳入临床指南的护理包干预措施进行经济评估时,存在着实际和方法上的挑战需要克服。通过制定有关方法的具体指南,例如明确确定相关成本,可以克服一些挑战。一些挑战需要就方法达成共识。然而,最大的挑战在于如何将服务质量的过程衡量标准作为有效性的衡量标准纳入其中。关于使用哪些衡量标准、如何组合多个衡量标准、如何比较一个领域的改进与另一个领域的改进以及与卫生工作者做法改进相关的价值是多少等问题仍有待回答。